二氧化碳激光艾灸治疗膝骨关节炎:多中心双盲随机对照试验方案
本方案为多中心、随机、双盲、安慰剂对照试验,计划招募392例膝骨关节炎患者,1:1分配至CO2激光艾灸组或假激光艾灸组,在6家门诊接受每周3次、共4周治疗,并随访20周。主要结局为第4周WOMAC疼痛评分变化,旨在评估CO2激光艾灸的疗效与安全性。
要点
- CO2激光艾灸模拟传统艾灸,无烟无味,便于双盲研究。
- 试验纳入392例膝骨关节炎患者,1:1随机分组。
- 主要结局为第4周WOMAC疼痛评分变化。
核心结论
- CO2激光艾灸装置作为传统艾灸的替代方法,易于使用和控制且无呛人烟雾和气味,是双盲研究的可行方法。
- 本研究将为CO2激光艾灸治疗膝骨关节炎的疗效和安全性提供严谨证据。
研究设计与样本
- 多中心、随机、双盲、安慰剂对照试验方案,在中国上海6家门诊招募392例参与者,按1:1比例分配至CO2激光艾灸组和假激光艾灸组。
- 两组均在患膝的犊鼻穴(ST 35)和阿是穴接受治疗,每周3次,共4周,并额外随访20周。
关键数值与推荐
- 主要结局为第4周WOMAC疼痛评分变化。
- 次要结局包括WOMAC功能评分、僵硬评分和总分、VAS疼痛、SF-36健康调查以及患者整体评估。
- 探索与膝骨关节炎进展相关的血清细胞因子水平,并在整个试验期间评估安全性。
- 由参与者和治疗提供者评估盲法有效性。
临床怎么用
- CO2激光艾灸可作为传统艾灸的替代方法用于膝骨关节炎治疗,但需等待本试验结果确认其疗效和安全性。
局限性
- 本文为试验方案,尚未报告研究结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Knee osteoarthritis (OA) is a major cause of disability among the older adults. Few treatments are safe and effective. Moxibustion is commonly used in treating knee OA in Chinese medicine (CM). CO2 Laser moxibustion device is a substitute for traditional moxibustion, which mimics the effects of traditional moxibustion. More data are needed to support its application in knee OA. OBJECTIVE: ObjectiveThe trial aims to assess the effect and safety of CO2 laser moxibustion in patients with knee osteoarthritis compared with a sham control. METHODS: This is a protocol for a multicenter, randomized, double-blind, placebo-controlled trial. A total of 392 participants were recruited and assigned to the CO2 laser moxibustion group and sham laser moxibustion group with a 1:1 ratio at 6 outpatient clinics in Shanghai, China. Participants in both groups received treatment at the affected knee(s) at the acupuncture point Dubi (ST 35) and an Ashi point. There were 3 sessions per week for 4 weeks, and an additional 20-week follow-up. Primary outcomes were changes in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain scores at week 4. Secondary outcomes were WOMAC function score, stiffness score and overall score, VAS pain, Short-Form heath survey (SF-36), and patients' global assessment. The serum levels of cytokines involved in progress of knee OA were explored. Safety was assessed during the whole trial. Masking effectiveness was assessed by both participants and treatment providers.This is a protocol for a multicenter, randomized, double-blind, placebo-controlled trial. A total of 392 participants were recruited and assigned to the CO2 laser moxibustion group and sham laser moxibustion group with a 1:1 ratio at 6 outpatient clinics in Shanghai, China. Participants in both groups received treatment at the affected knee(s) at the acupuncture point Dubi (ST 35) and an Ashi point. There were 3 sessions per week for 4 weeks, and an additional 20-week follow-up. Primary outcomes were changes in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain scores at week 4. Secondary outcomes were WOMAC function score, stiffness score and overall score, VAS pain, Short-Form heath survey (SF-36), and patients' global assessment. The serum levels of cytokines involved in progress of knee OA were explored. Safety was assessed during the whole trial. Masking effectiveness was assessed by both participants and treatment providers. DISCUSSION: CO2 laser moxibustion device, designed as a substitute for CM moxibustion, is easy to use and control with no choking smoke and smell, and is a plausible method for double-blind research. This study would provide rigorous evidence for the effect and safety of CO2 laser moxibustion in treating knee OA (Trial registration No.: ISRCTN15030019).
引用
- Guo MH, Zhao L, Wu F, et al. CO2 Laser Moxibustion for Knee Osteoarthritis: Study Protocol for A Multicenter, Double-blind, Randomized Controlled Trial. Chin J Integr Med. 2020. PMID: 31974753. doi:10.1007/s11655-019-2714-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。